PHARMACOKINETICS AND PHARMACODYNAMICS OF ENAVOGLIFLOZIN, AN SGLT-2 INHIBITOR, IN TYPE 2 DIABETES PATIENTS WITH IMPAIRED RENAL FUNCTION

被引：0
|
作者：
Kim, Y. [1 ]
Huh, K. [1 ]
Jeong, S. [2 ]
Cho, J. [3 ]
Huh, W. [3 ]
Shin, Y. [4 ]
Chung, J. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[2] Chungbuk Natl Univ Hosp, Cheongju, South Korea
[3] Daewoong Pharmaceut Co, Seoul, South Korea
[4] iN Therapeut, Yonginsi, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-015
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [21] Acute Renal Failure With Cocaine and SGLT-2 Inhibitor
    Shrivastava, Snehal
    Srivastava, Nishit
    Alfanso-Jaume, Maria
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) : E762 - E763
  • [22] The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments
    Garcia-Ropero, Alvaro
    Badimon, Juan J.
    Santos-Gallego, Carlos G.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) : 1287 - 1302
  • [23] Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment
    Kim, Hyun Ah
    Jang, Han Na
    Kong, Sung Hye
    Lee, Young
    Choi, Sung Hee
    Cho, Young Min
    Jang, Hak Chul
    Oh, Tae Jung
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (04) : 653 - 658
  • [24] Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
    Alkabbani, Wajd
    Gamble, John -Michael
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3057 - 3069
  • [25] Ertugliflozin: A New Option in the SGLT-2 Inhibitor Market for the Treatment of Type 2 Diabetes Mellitus
    Powell, Jason
    Garland, Scott G.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (05) : 478 - 485
  • [26] Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor
    Cichocka, Edyta
    Gumprecht, Janusz
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (06) : 522 - 523
  • [27] Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
    El Hage, Lea
    Kashyap, Sangeeta R.
    Rao, Pratibha
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2019, 10
  • [28] The role of SGLT-2 inhibitors in managing type 2 diabetes
    Tsushima, Yumiko
    Lansang, M. Cecilia
    Makin, Vinni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (01) : 47 - 58
  • [29] SGLT-2 inhibitors for people with type 2 diabetes Reply
    Zelniker, Thomas A.
    Wiviott, Stephen D.
    Raz, Itamar
    Sabatine, Marc S.
    LANCET, 2019, 394 (10198): : 560 - 561
  • [30] SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes
    Jia, Yu
    Liao, Xiaoyang
    ANNALS OF FAMILY MEDICINE, 2024, 22
12345